JC

Jorg Czech

BE Behringwerke: 6 patents #20 of 317Top 7%
Hoechst Gmbh: 5 patents #756 of 4,020Top 20%
AG Aventis Pharma Deutschland Gmbh: 2 patents #137 of 418Top 35%
LS Laboratories Hoechst S/A: 2 patents #11 of 27Top 45%
RU Roussel Uclaf: 1 patents #224 of 430Top 55%
Overall (All Time): #301,695 of 4,157,543Top 8%
16
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
7273727 Fusion proteins for prodrug activation Mathias Gehrmann, Gerhard Seeman, Klaus Bosslet 2007-09-25
7241595 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Cenek Kolar, Klaus Bosslet, Gerhard Seemann, Hans-Harald Sedlacek 2007-07-10
7060495 Fusion proteins for prodrug activation Mathias Gehrmann, Gerhard Seemann, Klaus Bosslet 2006-06-13
6610299 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Cenek Kolar, Klaus Bosslet, Gerhard Seemann, Hans-Harald Sedlacek, Dieter Hoffmann 2003-08-26
6475486 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Cenek Kolar, Klaus Bosslet, Gerhard Seemann, Hans-Harald Sedlacek, Dieter Hoffman 2002-11-05
6146658 Prodrugs, their preparation and use as pharmaceuticals Klaus Bosslet, Dieter Hoffmann, Cenek Kolar, François Tillequin, Jean-Claude Florent +5 more 2000-11-14
6020315 Preparation having increased in vivo tolerability Klaus Bosslet, Manfred Gerken, Rainer Straub, Matthias Blumrich 2000-02-01
6020372 Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders Wilfried Schwab, Klaus Boslett 2000-02-01
5955100 Prodrugs their preparation and use as pharmaceuticals Klaus Bosslet, Dieter Hoffmann, Cenek Kolar, François Tillequin, Jean-Claude Florent +5 more 1999-09-21
5935995 Prodrugs for the therapy of tumors and inflammatory disorders Klaus Bosslet, Manfred Gerken, Rainer Straub, Claude Monneret, Jean-Claude Florent +1 more 1999-08-10
5886033 Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders Wilfried Schwab, Klaus Boslett 1999-03-23
5877158 Pro-prodrugs, their production and use Klaus Bosslet, Dieter Hoffmann, François Tillequin, Jean-Claude Florent, Michel Azoulay +4 more 1999-03-02
5817800 Inhibitors of .beta.-glucuronidase and their use in the treatment of carcinamatosis and inflammation Klaus Bosslet, Andrea Vasella, Roland Hoos 1998-10-06
5710134 Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders Klaus Bosslet, Dieter Hoffmann 1998-01-20
5519018 Substituted phenols and their use for the treatment of disorders caused by cell proliferation Rudolf Matusch, Manfred Hunz, Hans-Harald Sedlacek 1996-05-21
5189065 Use of derivatives of 9,10-dihydrophenanthrene for the preparation of an anti-tumor medicament Hans-Harald Sedlacek, Lucien Nedelec, Jacques Guillaume, Christian Marchandeau 1993-02-23